Solara Active Pharma Sciences Limited (SOLARA.BO)
INR 509.6
(3.02%)
INR 509.6
(3.02%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 10.02 Billion INR | -0.12% |
| 2022 | 10.04 Billion INR | 1.32% |
| 2021 | 9.9 Billion INR | 134.25% |
| 2020 | 4.23 Billion INR | -36.48% |
| 2019 | 6.65 Billion INR | 44.03% |
| 2018 | 4.62 Billion INR | -21.24% |
| 2017 | 5.87 Billion INR | 5871040.0% |
| 2016 | -100 Thousand INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 8.13 Billion INR | 9598.14% |
| 2024 Q1 | 86 Million INR | -99.14% |
| 2023 FY | 10.02 Billion INR | -0.12% |
| 2023 Q4 | 10.02 Billion INR | 15424.77% |
| 2023 Q1 | 88.9 Million INR | -99.11% |
| 2023 Q3 | 64.6 Million INR | -99.34% |
| 2023 Q2 | 9.78 Billion INR | 10907.31% |
| 2022 Q4 | 10.04 Billion INR | 30891.36% |
| 2022 FY | 10.04 Billion INR | 1.32% |
| 2022 Q1 | 463.8 Million INR | -95.32% |
| 2022 Q3 | 32.4 Million INR | -99.67% |
| 2022 Q2 | 9.7 Billion INR | 1991.59% |
| 2021 FY | 9.9 Billion INR | 134.25% |
| 2021 Q1 | 1.97 Billion INR | -53.27% |
| 2021 Q2 | 7.55 Billion INR | 282.31% |
| 2021 Q3 | 966.8 Million INR | -87.21% |
| 2021 Q4 | 9.9 Billion INR | 925.02% |
| 2020 Q3 | 4.08 Billion INR | 141.56% |
| 2020 Q1 | 560.4 Million INR | -91.59% |
| 2020 FY | 4.23 Billion INR | -36.48% |
| 2020 Q4 | 4.23 Billion INR | 3.46% |
| 2020 Q2 | 1.69 Billion INR | 202.05% |
| 2019 Q1 | 761.59 Million INR | -83.53% |
| 2019 FY | 6.65 Billion INR | 44.03% |
| 2019 Q4 | 6.65 Billion INR | 187.06% |
| 2019 Q3 | 2.32 Billion INR | -50.23% |
| 2019 Q2 | 4.66 Billion INR | 512.01% |
| 2018 Q3 | 77 Million INR | -98.71% |
| 2018 Q1 | 471.79 Million INR | -91.96% |
| 2018 FY | 4.62 Billion INR | -21.24% |
| 2018 Q2 | 5.96 Billion INR | 1164.78% |
| 2018 Q4 | 4.62 Billion INR | 5905.06% |
| 2017 Q4 | 5.87 Billion INR | 13.88% |
| 2017 FY | 5.87 Billion INR | 5871040.0% |
| 2017 Q3 | 5.15 Billion INR | 0.0% |
| 2016 FY | -100 Thousand INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | -159.422% |
| Aurobindo Pharma Limited | 3.69 Billion INR | -171.546% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 452.803% |
| Granules India Limited | 9.28 Billion INR | -7.992% |
| Indoco Remedies Limited | 6.47 Billion INR | -54.857% |
| Achyut Healthcare Limited | -3.74 Million INR | 267825.574% |
| Ajanta Pharma Limited | -954.9 Million INR | 1150.267% |
| Alkem Laboratories Limited | -1.6 Billion INR | 723.151% |
| Alpa Laboratories Limited | 35.36 Million INR | -28260.15% |
| Brooks Laboratories Limited | 49.48 Million INR | -20166.747% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 300.082% |
| Bajaj HealthCare Limited | 3.29 Billion INR | -204.005% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 966.248% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 22.334% |
| Eris Lifesciences Limited | 13.8 Billion INR | 27.36% |
| FDC Limited | -57.75 Million INR | 17465.632% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 334.035% |
| Gufic Biosciences Limited | 3.19 Billion INR | -213.964% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 341.485% |
| Ipca Laboratories Limited | 11.41 Billion INR | 12.143% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 821.547% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -418.852% |
| Lasa Supergenerics Limited | 205.79 Million INR | -4773.202% |
| Laurus Labs Limited | 24.38 Billion INR | 58.872% |
| Lupin Limited | 17.19 Billion INR | 41.666% |
| Mankind Pharma Limited | -9.9 Billion INR | 201.221% |
| Medicamen Biotech Limited | 160.31 Million INR | -6155.77% |
| Medico Remedies Limited | 78.67 Million INR | -12647.054% |
| Megasoft Limited | 1.28 Billion INR | -680.132% |
| NATCO Pharma Limited | -5.81 Billion INR | 272.408% |
| Piramal Pharma Limited | 42.27 Billion INR | 76.277% |
| RPG Life Sciences Limited | -364.7 Million INR | 2849.931% |
| Sigachi Industries Limited | 859.94 Million INR | -1066.232% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 113.839% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -6817.697% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -21602.625% |
| Unichem Laboratories Limited | 931.91 Million INR | -976.17% |
| Wanbury Limited | 1.1 Billion INR | -806.884% |
| Windlas Biotech Limited | -273.04 Million INR | 3773.088% |
| ZIM Laboratories Limited | 983.6 Million INR | -919.618% |
| Zydus Lifesciences Limited | 3.91 Billion INR | -156.365% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 1164.876% |
| Divi's Laboratories Limited | -39.77 Billion INR | 125.218% |
| Hester Biosciences Limited | 2.29 Billion INR | -337.806% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 527.129% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 4131.078% |
| Bal Pharma Limited | 1.26 Billion INR | -693.709% |
| Strides Pharma Science Limited | 23.25 Billion INR | 56.877% |
| Venus Remedies Limited | -267.7 Million INR | 3846.358% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | -283.973% |
| Nectar Lifesciences Limited | 6.15 Billion INR | -62.88% |
| Shilpa Medicare Limited | 9.06 Billion INR | -10.579% |
| Aarti Drugs Limited | 5.54 Billion INR | -80.755% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 1010.651% |
| Suven Life Sciences Limited | -1.63 Billion INR | 714.259% |
| Ind-Swift Limited | 9.5 Billion INR | -5.473% |
| Valiant Laboratories Limited | -295.03 Million INR | 3499.292% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | -255.487% |
| Themis Medicare Limited | 764.96 Million INR | -1211.046% |
| Hikal Limited | 7.96 Billion INR | -25.882% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 68.492% |
| Sequent Scientific Limited | 4.17 Billion INR | -140.007% |
| Novartis India Limited | -5.89 Billion INR | 270.24% |
| Wockhardt Limited | 18.27 Billion INR | 45.107% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 62.954% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 54469.511% |
| Neuland Laboratories Limited | -214.05 Million INR | 4785.179% |
| Morepen Laboratories Limited | -231.17 Million INR | 4438.291% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -8254.785% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | -927.76% |